Literature DB >> 18562151

Ethanol inhibition of recombinant NMDA receptors is not altered by coexpression of CaMKII-alpha or CaMKII-beta.

Minfu Xu1, L Judson Chandler, John J Woodward.   

Abstract

Previous studies have shown that the N-methyl-d-aspartate (NMDA) receptor is an important target for the actions of ethanol in the brain. N-methyl-d-aspartate receptors are glutamate-activated ion channels that are highly expressed in neurons. They are activated during periods of significant glutamatergic synaptic activity and are an important source of the signaling molecule calcium in the postsynaptic spine. Alterations in the function of NMDA receptors by drugs or disease are associated with deficits in motor, sensory and cognitive processes of the brain. Acutely, ethanol inhibits ion flow through NMDA receptors whereas sustained exposure to ethanol can induce compensatory changes in the density and localization of the receptor. Defining factors that govern the acute ethanol sensitivity of NMDA receptors is an important step in understanding how an individual responds to ethanol. In the present study, we investigated the effect of calcium-calmodulin dependent protein kinase II (CaMKII) on the ethanol sensitivity of recombinant NMDA receptors. Calcium-calmodulin dependent protein kinase II is a major constituent of the postsynaptic density and is critically involved in various forms of learning and memory. NMDA receptor subunits were transiently expressed in human embryonic kidney 293 cells along with CaMKII-alpha or CaMKII-beta tagged with the green fluorescent protein. Whole cell currents were elicited by brief exposures to glutamate and were measured using patch-clamp electrophysiology. Neither CaMKII-alpha or CaMKII-beta had any significant effect on the ethanol inhibition of NR1/2A or NR1/2B receptors. Ethanol inhibition was also unaltered by deletion of CaMKII binding domains in NR1 or NR2 subunits or by phospho-site mutants that mimic or occlude CaMKII phosphorylation. Chronic treatment of cortical neurons with ethanol had no significant effect on the expression of CaMKII-alpha or CaMKII-beta. The results of this study suggest that CaMKII is not involved in regulating the acute ethanol sensitivity of NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562151      PMCID: PMC2629600          DOI: 10.1016/j.alcohol.2008.04.007

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  39 in total

1.  Fyn tyrosine kinase reduces the ethanol inhibition of recombinant NR1/NR2A but not NR1/NR2B NMDA receptors expressed in HEK 293 cells.

Authors:  D L Anders; T Blevins; G Sutton; S Swope; L J Chandler; J J Woodward
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

Review 2.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

3.  CaM kinase II phosphorylation of slo Thr107 regulates activity and ethanol responses of BK channels.

Authors:  Jianxi Liu; Maria Asuncion-Chin; Pengchong Liu; Alejandro M Dopico
Journal:  Nat Neurosci       Date:  2005-12-11       Impact factor: 24.884

Review 4.  Alcohols and neurotransmitter gated ion channels: past, present and future.

Authors:  D M Lovinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-09       Impact factor: 3.000

5.  Protein kinase Cgamma mediates ethanol withdrawal hyper-responsiveness of NMDA receptor currents in spinal cord motor neurons.

Authors:  Hui-Fang Li; Daria Mochly-Rosen; Joan J Kendig
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

6.  CaMKIIalpha enhances the desensitization of NR2B-containing NMDA receptors by an autophosphorylation-dependent mechanism.

Authors:  Suzanne Sessoms-Sikes; Yumiko Honse; David M Lovinger; Roger J Colbran
Journal:  Mol Cell Neurosci       Date:  2005-05       Impact factor: 4.314

7.  Fyn kinase does not reduce ethanol inhibition of zinc-insensitive NR2A-containing N-methyl-D-aspartate receptors.

Authors:  John J Woodward
Journal:  Alcohol       Date:  2004 Oct-Nov       Impact factor: 2.405

8.  Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function.

Authors:  T Miyakawa; T Yagi; H Kitazawa; M Yasuda; N Kawai; K Tsuboi; H Niki
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

9.  Calcium/calmodulin-dependent protein kinase II is associated with the N-methyl-D-aspartate receptor.

Authors:  A S Leonard; I A Lim; D E Hemsworth; M C Horne; J W Hell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

10.  Effects of c-Src tyrosine kinase on ethanol sensitivity of recombinant NMDA receptors expressed in HEK 293 cells.

Authors:  D L Anders; T Blevins; G Sutton; L J Chandler; J J Woodward
Journal:  Alcohol Clin Exp Res       Date:  1999-02       Impact factor: 3.455

View more
  10 in total

1.  CaMKII activation is a novel effector of alcohol's neurotoxicity in neural crest stem/progenitor cells.

Authors:  Ana Garic; George R Flentke; Ed Amberger; Marcos Hernandez; Susan M Smith
Journal:  J Neurochem       Date:  2011-05-13       Impact factor: 5.372

2.  Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.

Authors:  Christopher L German; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurochem       Date:  2012-08-23       Impact factor: 5.372

3.  Effects of ethanol on phosphorylation site mutants of recombinant N-methyl-D-aspartate receptors.

Authors:  Minfu Xu; Corigan Thetford Smothers; John J Woodward
Journal:  Alcohol       Date:  2010-12-15       Impact factor: 2.405

Review 4.  Ethanol effects on N-methyl-D-aspartate receptors in the bed nucleus of the stria terminalis.

Authors:  Tiffany A Wills; Danny G Winder
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

5.  Dephosphorylation of GluN2B C-terminal tyrosine residues does not contribute to acute ethanol inhibition of recombinant NMDA receptors.

Authors:  Benjamin A Hughes; C Thetford Smothers; John J Woodward
Journal:  Alcohol       Date:  2013-01-26       Impact factor: 2.405

Review 6.  Neuroscience of alcoholism: molecular and cellular mechanisms.

Authors:  Sachin Moonat; Bela G Starkman; Amul Sakharkar; Subhash C Pandey
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

7.  The Memory-Enhancing Effects of Liquiritigenin by Activation of NMDA Receptors and the CREB Signaling Pathway in Mice.

Authors:  Yong-Hyun Ko; Seung-Hwan Kwon; Ji-Young Hwang; Kyung-In Kim; Jee-Yeon Seo; Thi-Lien Nguyen; Seok-Yong Lee; Hyoung-Chun Kim; Choon-Gon Jang
Journal:  Biomol Ther (Seoul)       Date:  2018-03-01       Impact factor: 4.634

8.  Alcohol exposure alters NMDAR function in the bed nucleus of the stria terminalis.

Authors:  Thomas L Kash; Anthony J Baucum; Kelly L Conrad; Roger J Colbran; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2009-06-24       Impact factor: 7.853

9.  αCaMKII autophosphorylation controls the establishment of alcohol drinking behavior.

Authors:  Alanna C Easton; Walter Lucchesi; Anbarasu Lourdusamy; Bernd Lenz; Jalal Solati; Yulia Golub; Piotr Lewczuk; Cathy Fernandes; Sylvane Desrivieres; Ralph R Dawirs; Gunther H Moll; Johannes Kornhuber; Josef Frank; Per Hoffmann; Michael Soyka; Falk Kiefer; Gunter Schumann; K Peter Giese; Christian P Müller; Jens Treutlein; Sven Cichon; Monika Ridinger; Peter Mattheisen; Stefan Herms; Norbert Wodarz; Peter Zill; Wolfgang Maier; Rainald Mössner; Wolfgang Gaebel; Norbert Dahmen; Norbert Scherbaum; Christine Schmäl; Michael Steffens; Susanne Lucae; Marcus Ising; Bertram Müller-Myhsok; Markus M Nöthen; Karl Mann; Marcella Rietschel
Journal:  Neuropsychopharmacology       Date:  2013-03-04       Impact factor: 7.853

10.  Mechanisms of Neuroplasticity and Ethanol's Effects on Plasticity in the Striatum and Bed Nucleus of the Stria Terminalis.

Authors:  David M Lovinger; Thomas L Kash
Journal:  Alcohol Res       Date:  2015
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.